title: Does a reduced 11 beta HSD type 2 activity contribute to sodium retention in the nephrotic syndrome?
authors.forename: Michiel N
authors.initials: MN
authors.lastname: Kerstens
authors.forename: Gerjan
authors.initials: G
authors.lastname: Navis
authors.forename: Robin P F
authors.initials: RP
authors.lastname: Dullaart
mesh_terms: D042842:11-beta-Hydroxysteroid Dehydrogenases; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000097:blood; D003345:Corticosterone / Q000097:blood; D004195:Disease Models, Animal; D006801:Humans; D006913:Hydroxysteroid Dehydrogenases / Q000652:urine*; D009404:Nephrotic Syndrome / Q000097:blood / Q000201:enzymology* / Q000652:urine*; D011237:Predictive Value of Tests; D051381:Rats; D014883:Water-Electrolyte Imbalance / Q000097:blood / Q000201:enzymology* / Q000652:urine*
chemical_list: D000893:Anti-Inflammatory Agents; D006913:Hydroxysteroid Dehydrogenases; D042842:11-beta-Hydroxysteroid Dehydrogenases; D003345:Corticosterone